Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Sales (2017 - 2025)

Arcus Biosciences (RCUS) has 9 years of Return on Sales data on record, last reported at 10.93% in Q4 2025.

  • For Q4 2025, Return on Sales changed N/A year-over-year to 10.93%; the TTM value through Dec 2025 reached 1.36%, changed N/A, while the annual FY2025 figure was 1.43%, 7218.0% down from the prior year.
  • Return on Sales reached 10.93% in Q4 2025 per RCUS's latest filing, down from 1.77% in the prior quarter.
  • Across five years, Return on Sales topped out at 1.26% in Q3 2024 and bottomed at 10.93% in Q4 2025.
  • Average Return on Sales over 5 years is 3.33%, with a median of 2.58% recorded in 2025.
  • The widest YoY moves for Return on Sales: up 1773bps in 2021, down -827bps in 2021.
  • A 5-year view of Return on Sales shows it stood at 0.79% in 2021, then plummeted by -353bps to 1.99% in 2022, then crashed by -31bps to 2.61% in 2023, then surged by 148bps to 1.26% in 2024, then plummeted by -968bps to 10.93% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 10.93% in Q4 2025, 1.77% in Q3 2025, and 2.58% in Q2 2025.